InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Normocin® - Antimicrobial Reagent | Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV... | 2023 | NPJ Vaccines | Nanishi E. et al. | DOI: 10.1038/s41541-023-00610-4 |
| QUANTI-Blue™ | Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV... | 2023 | NPJ Vaccines | Nanishi E. et al. | DOI: 10.1038/s41541-023-00610-4 |
| THP1-Dual™ Cells | Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV... | 2023 | NPJ Vaccines | Nanishi E. et al. | DOI: 10.1038/s41541-023-00610-4 |
| H4-derived Anti-SARS-CoV2 RBD mAbs, human & mouse isotypes | Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV... | 2023 | NPJ Vaccines | Nanishi E. et al. | DOI: 10.1038/s41541-023-00610-4 |
| AddaVax™ | Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV... | 2023 | NPJ Vaccines | Nanishi E. et al. | DOI: 10.1038/s41541-023-00610-4 |
| Human ACE2 Protein | Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV... | 2023 | NPJ Vaccines | Nanishi E. et al. | DOI: 10.1038/s41541-023-00610-4 |
| THP1-Dual™ KO-MyD88 Cells | Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV... | 2023 | NPJ Vaccines | Nanishi E. et al. | DOI: 10.1038/s41541-023-00610-4 |
| AddaS03™ Adjuvant | Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV... | 2023 | NPJ Vaccines | Nanishi E. et al. | DOI: 10.1038/s41541-023-00610-4 |
| Primocin® | Transcriptome of GH-producing pituitary neuroendocrine tumours and models are... | 2023 | Cancer Cell Int. | Saksis R. et al. | DOI: 10.1186/s12935-023-02863-4 |
| MDP | Effects of a co-stimulation with S-PRG filler eluate and muramyl dipeptide (M... | 2023 | Dent Mater J. | Moroto H. et al. | DOI: 10.4012/dmj.2022-201 |
| Recombinant human TGF-β1 | Targeting serotonin receptor 2B inhibits TGFβ induced differentiation of huma... | 2023 | Eur J Pharmacol. | Wenglén C. et al. | DOI: 10.1016/j.ejphar.2023.175570 |
| Primocin® | Simple Technique for Microscopic Evaluation of Active Cellular Invasion into ... | 2023 | ACS Biomater Sci Eng. | Simpson C.R. et al. | DOI: 10.1021/acsbiomaterials.2c01015 |
| LPS-EB VacciGrade™ | The novel hepatoprotective mechanisms of silibinin-phospholipid complex again... | 2023 | Int Immunopharmacol | Tang S. et al. | DOI: 10.1016/j.intimp.2023.109808 |
| Anti-hIL-29 Neutralizing mAb | X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life... | 2023 | Sci Immunol. | Asano T. et al. | DOI: 10.1126/sciimmunol.abl4348 |
| TL8-506 | X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life... | 2023 | Sci Immunol. | Asano T. et al. | DOI: 10.1126/sciimmunol.abl4348 |
| R848 (Resiquimod) | X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life... | 2023 | Sci Immunol. | Asano T. et al. | DOI: 10.1126/sciimmunol.abl4348 |
| Imiquimod (R837) | X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life... | 2023 | Sci Immunol. | Asano T. et al. | DOI: 10.1126/sciimmunol.abl4348 |
| pFUSE-CHIg-hG1 | Analysis of the in vitro function and internalization ability of a humanized ... | 2023 | Protein Expr Purif. | Wu H. et al. | DOI: 10.1016/j.pep.2023.106243 |
| pFUSE2-CLIg-hK | Analysis of the in vitro function and internalization ability of a humanized ... | 2023 | Protein Expr Purif. | Wu H. et al. | DOI: 10.1016/j.pep.2023.106243 |
| LPS-EB (LPS from E. coli O111:B4) | Intestinal Epithelial Cells Adapt to Chronic Inflammation through Partial Gen... | 2023 | Cancers (Basel) | Collin G. et al. | DOI: 10.3390/cancers15030973 |